Accolade, Inc. ACCD
We take great care to ensure that the data presented and summarized in this overview for Accolade, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ACCD
View all-
Brown Advisory Inc5.85MShares$43.7 Million0.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$42.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.61MShares$42 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$40.4 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY5.33MShares$39.9 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.8MShares$35.9 Million0.79% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$28.3 Million88.81% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3.54MShares$26.5 Million0.97% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.38MShares$17.8 Million0.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.02MShares$15.1 Million0.01% of portfolio
Latest Institutional Activity in ACCD
Top Purchases
Top Sells
About ACCD
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Insider Transactions at ACCD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2024
|
Stephen H. Barnes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
214
-0.12%
|
$1,498
$7.44 P/Share
|
|
May 13
2024
|
Rajeev Singh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
640
-0.09%
|
$4,480
$7.44 P/Share
|
|
May 13
2024
|
Robert N Cavanaugh President |
SELL
Open market or private sale
|
Direct |
206
-0.12%
|
$1,442
$7.44 P/Share
|
|
May 10
2024
|
Stephen H. Barnes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
770
+0.43%
|
-
|
|
May 10
2024
|
Michael W Hilton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
183
+0.12%
|
-
|
|
May 10
2024
|
Rajeev Singh Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,650
+0.22%
|
-
|
|
May 10
2024
|
Robert N Cavanaugh President |
BUY
Exercise of conversion of derivative security
|
Direct |
710
+0.41%
|
-
|
|
May 02
2024
|
Colin Mc Hugh Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
424
-1.11%
|
$2,968
$7.28 P/Share
|
|
May 02
2024
|
Richard Eskew EVP General Counsel |
SELL
Open market or private sale
|
Direct |
462
-1.14%
|
$3,234
$7.28 P/Share
|
|
May 01
2024
|
Colin Mc Hugh Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,232
+1.58%
|
-
|
|
May 01
2024
|
Richard Eskew EVP General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,638
+1.98%
|
-
|
|
Apr 18
2024
|
Robert N Cavanaugh President |
SELL
Open market or private sale
|
Direct |
141
-0.08%
|
$1,128
$8.82 P/Share
|
|
Apr 18
2024
|
Stephen H. Barnes Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
109
-0.06%
|
$872
$8.82 P/Share
|
|
Apr 18
2024
|
Michael W Hilton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
331
+0.22%
|
-
|
|
Apr 18
2024
|
Rajeev Singh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
355
-0.05%
|
$2,840
$8.82 P/Share
|
|
Apr 17
2024
|
Robert N Cavanaugh President |
BUY
Exercise of conversion of derivative security
|
Direct |
510
+0.29%
|
-
|
|
Apr 17
2024
|
Stephen H. Barnes Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
414
+0.23%
|
-
|
|
Apr 17
2024
|
Rajeev Singh Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
933
+0.12%
|
-
|
|
Apr 11
2024
|
Robert N Cavanaugh President |
SELL
Open market or private sale
|
Direct |
253
-0.15%
|
$2,024
$8.85 P/Share
|
|
Apr 11
2024
|
Rajeev Singh Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
667
-0.09%
|
$5,336
$8.85 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 987K shares |
|---|---|
| Grant, award, or other acquisition | 7.12K shares |
| Open market or private sale | 189K shares |
|---|